title: Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?
authors.forename: Sandra M
authors.initials: SM
authors.lastname: Arend
authors.forename: Dick
authors.initials: D
authors.lastname: van Soolingen
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology; D001691:Biological Therapy / Q000009:adverse effects* / Q000379:methods; D024881:Drug Resistance, Bacterial; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects* / Q000379:methods; D007538:Isoniazid / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009163:Mycobacterium bovis / Q000187:drug effects* / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid